サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701859

プレフィルドシリンジ市場レポート：設計別、材料別、クロージングシステム別、用途別、エンドユーザー別、地域別、2025年～2033年

Prefilled Syringes Market Report by Design, Material, Closing System, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 146 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
プレフィルドシリンジ市場レポート：設計別、材料別、クロージングシステム別、用途別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

プレフィルドシリンジ市場の世界市場規模は2024年に82億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに158億米ドルに達し、2025年から2033年にかけて7.58%の成長率（CAGR）を示すと予測しています。生物製剤の需要増加、便利で安全な自己投与への嗜好の高まり、先進的で汚染のないドラッグデリバリーシステムの採用を促進する厳しい規制基準などにより、現在、欧州が世界最大の市場シェアを占めています。

プレフィルドシリンジは、注射用ワクチンの1回分ずつ包装されたもので、本来は使い捨てです。プレフィルドシリンジを使用することで、薬剤バイアルにシリンジを挿入して投与量を取り出す際に起こりうる混注関連の汚染リスクを回避できるため、薬剤汚染の可能性が大幅に低下します。滅菌済みシリンジと組み合わせることで、安全性がさらに高まり、緊急時にドラッグデリバリーを簡単かつ迅速に行うことができ、現場でのバイアル洗浄や脱パイロジェン化工程が不要になります。その結果、バイオシミラーや生物学的製剤のような様々な注射剤を非経口的に投与するための好ましい選択肢となっています。

プレフィルドシリンジ市場動向：

世界市場は主に、糖尿病や自己免疫疾患などの慢性疾患の増加によって牽引されています。これは、プレフィラブルシリンジに充填された生物学的製剤を使用して慢性疾患を治療する需要が高まっていることも後押ししています。これに加えて、ヘルスケア専門家によるプレフィルドシリンジ製品の広範な採用や、主要企業による新製品の発売数の増加も市場を促進しています。さらに、大幅な技術進歩に伴い、自己注射式非経口デバイスの導入も増加しており、これも市場の成長に寄与しています。また、世界レベルでの老年人口の増加や、ヘルスケアインフラ全体の改善への投資の増加も市場を牽引しています。その他にも、針刺し刺入防止法に関する政府の支持的な規制、プレフィルドシリンジの利点に関する意識の高まり、在宅医療への嗜好の広がり、製薬環境全体における生物製剤およびバイオシミラーの人気の高まりなどが、市場に有利な成長機会をさらに生み出しています。

本レポートで扱う主な質問

  • 2024年の世界のプレフィルドシリンジ市場の市場規模は？
  • 2025-2033年の世界のプレフィルドシリンジ市場の予想成長率は？
  • 世界のプレフィルドシリンジ市場を牽引する主要因は何か？
  • 世界のプレフィルドシリンジ市場に対するCOVID-19の影響は？
  • 世界のプレフィルドシリンジ市場の設計別内訳は？
  • 世界のプレフィルドシリンジ市場の材料別の内訳は？
  • 世界のプレフィルドシリンジ市場の、クロージングシステムに基づく内訳は？
  • 世界のプレフィルドシリンジ市場のエンドユーザー別の内訳は？
  • 世界のプレフィルドシリンジ市場における主要地域は？
  • 世界のプレフィルドシリンジ市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のプレフィルドシリンジ市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：設計別

  • シングルチャンバープレフィルドシリンジ
  • デュアルチャンバープレフィルドシリンジ
  • カスタマイズされたプレフィルドシリンジ

第7章 市場内訳：材料別

  • ガラスプレフィルドシリンジ
  • プラスチック製プレフィルドシリンジ

第8章 市場内訳：クロージングシステム別

  • ステークドニードルシステム
  • ルアーコーンシステム
  • ルアーロックフォームシステム

第9章 市場内訳：用途別

  • 糖尿病
  • アナフィラキシー
  • 関節リウマチ
  • 腫瘍学
  • その他

第10章 市場内訳：エンドユーザー別

  • 病院
  • クリニック
  • その他

第11章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Bayer AG
    • Becton Dickinson and Company
    • Cardinal Health Inc.
    • Catalent Inc.
    • Fresenius SE & Co. KGaA
    • Gerresheimer AG
    • Nipro Corporation
    • Schott AG
    • Terumo Corporation
    • West Pharmaceutical Services Inc.
図表

List of Figures

  • Figure 1: Global: Prefilled Syringes Market: Major Drivers and Challenges
  • Figure 2: Global: Prefilled Syringes Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Prefilled Syringes Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Prefilled Syringes Market: Breakup by Design (in %), 2024
  • Figure 5: Global: Prefilled Syringes Market: Breakup by Material (in %), 2024
  • Figure 6: Global: Prefilled Syringes Market: Breakup by Closing System (in %), 2024
  • Figure 7: Global: Prefilled Syringes Market: Breakup by Application (in %), 2024
  • Figure 8: Global: Prefilled Syringes Market: Breakup by End User (in %), 2024
  • Figure 9: Global: Prefilled Syringes Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Prefilled Syringes (Single-chamber Prefilled Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Prefilled Syringes (Single-chamber Prefilled Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Prefilled Syringes (Dual-chamber Prefilled Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Prefilled Syringes (Dual-chamber Prefilled Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Prefilled Syringes (Customized Prefilled Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Prefilled Syringes (Customized Prefilled Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Prefilled Syringes (Glass Prefilled Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Prefilled Syringes (Glass Prefilled Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Prefilled Syringes (Plastic Prefilled Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Prefilled Syringes (Plastic Prefilled Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Prefilled Syringes (Staked Needle System) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Prefilled Syringes (Staked Needle System) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Prefilled Syringes (Luer Cone System) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Prefilled Syringes (Luer Cone System) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Prefilled Syringes (Luer Lock Form System) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Prefilled Syringes (Luer Lock Form System) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Prefilled Syringes (Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Prefilled Syringes (Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Prefilled Syringes (Anaphylaxis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Prefilled Syringes (Anaphylaxis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Prefilled Syringes (Rheumatoid Arthritis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Prefilled Syringes (Rheumatoid Arthritis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Prefilled Syringes (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Prefilled Syringes (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Prefilled Syringes (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Prefilled Syringes (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Prefilled Syringes (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Prefilled Syringes (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Prefilled Syringes (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Prefilled Syringes (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Prefilled Syringes (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Prefilled Syringes (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: North America: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: North America: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: United States: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: United States: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Canada: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Canada: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Asia-Pacific: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Asia-Pacific: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: China: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: China: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Japan: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Japan: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: India: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: India: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: South Korea: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: South Korea: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Australia: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Australia: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Indonesia: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Indonesia: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Europe: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Europe: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Germany: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Germany: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: France: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: France: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: United Kingdom: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: United Kingdom: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Italy: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Italy: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Spain: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Spain: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Russia: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Russia: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Latin America: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Latin America: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Brazil: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Brazil: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Mexico: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Mexico: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Others: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Others: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Middle East and Africa: Prefilled Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Middle East and Africa: Prefilled Syringes Market: Breakup by Country (in %), 2024
  • Figure 90: Middle East and Africa: Prefilled Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Global: Prefilled Syringes Industry: SWOT Analysis
  • Figure 92: Global: Prefilled Syringes Industry: Value Chain Analysis
  • Figure 93: Global: Prefilled Syringes Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Prefilled Syringes Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Prefilled Syringes Market Forecast: Breakup by Design (in Million USD), 2025-2033
  • Table 3: Global: Prefilled Syringes Market Forecast: Breakup by Material (in Million USD), 2025-2033
  • Table 4: Global: Prefilled Syringes Market Forecast: Breakup by Closing System (in Million USD), 2025-2033
  • Table 5: Global: Prefilled Syringes Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: Prefilled Syringes Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 7: Global: Prefilled Syringes Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Prefilled Syringes Market: Competitive Structure
  • Table 9: Global: Prefilled Syringes Market: Key Players
目次
Product Code: SR112025A6033

The global prefilled syringes market size reached USD 8.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.8 Billion by 2033, exhibiting a growth rate (CAGR) of 7.58% during 2025-2033. At present, Europe holds the largest market share across the globe due to the increasing demand for biologics, a growing preference for convenient and safe self-administration, and stringent regulatory standards promoting the adoption of advanced, contamination-free drug delivery systems.

A prefilled syringe is a single-dose packet of injectable vaccines that is disposable in nature. The usage of prefilled syringes significantly lowers the chances of drug contamination as it avoids the potential admixture-related contamination risks when syringes are inserted into a drug vial to draw out a dose. Combining this with a pre-sterilized syringe further increases safety, enables the easy and quick delivery of drugs in the case of emergencies, and eliminates the additional on-site vial cleaning and de-pyrogenation processes. Consequently, they are a preferred option to administer the drugs via the parenteral route for delivering a wide range of injectables, such as biosimilar and biologics.

Prefilled Syringes Market Trends:

The global market is primarily driven by the increasing incidences of chronic diseases, including diabetes and autoimmune diseases. This is further supported by the growing demand for treating chronic medical conditions using biological drugs in pre-fillable syringes. In addition to this, the widespread adoption of the prefilled syringe products by healthcare professionals and the escalating number of new product launches by key players are also fostering the market. Moreover, with significant technological advancements, the implementations of self-injecting parenteral devices are also increasing, which, in turn, is contributing to the market growth. The market is also driven by the rising geriatric population on the global level and growing investments in improving the overall healthcare infrastructure. Other factors, such as supportive government regulations regarding needlestick legislation, the rising consciousness regarding the advantages of prefilled syringes, the widespread preference for home-based healthcare, and the increasing popularity of biologics and biosimilars across the pharmaceutical settings, are further creating lucrative growth opportunities in the market.

Key Market Segmentation:

Breakup by Design:

  • Single-chamber Prefilled Syringes
  • Dual-chamber Prefilled Syringes
  • Customized Prefilled Syringes

Breakup by Material:

  • Glass Prefilled Syringes
  • Plastic Prefilled Syringes

Breakup by Closing System:

  • Staked Needle System
  • Luer Cone System
  • Luer Lock Form System

Breakup by Application:

  • Diabetes
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Oncology
  • Others

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Baxter International Inc., Bayer AG, Becton Dickinson and Company, Cardinal Health Inc., Catalent Inc., Fresenius SE & Co. KGaA, Gerresheimer AG, Nipro Corporation, Schott AG, Terumo Corporation and West Pharmaceutical Services Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global prefilled syringes market in 2024?
  • 2.What is the expected growth rate of the global prefilled syringes market during 2025-2033?
  • 3.What are the key factors driving the global prefilled syringes market?
  • 4.What has been the impact of COVID-19 on the global prefilled syringes market?
  • 5.What is the breakup of the global prefilled syringes market based on the design?
  • 6.What is the breakup of the global prefilled syringes market based on the material?
  • 7.What is the breakup of the global prefilled syringes market based on closing system?
  • 8.What is the breakup of the global prefilled syringes market based on the end user?
  • 9.What are the key regions in the global prefilled syringes market?
  • 10.Who are the key players/companies in the global prefilled syringes market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Prefilled Syringes Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Design

  • 6.1 Single-chamber Prefilled Syringes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Dual-chamber Prefilled Syringes
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Customized Prefilled Syringes
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Material

  • 7.1 Glass Prefilled Syringes
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Plastic Prefilled Syringes
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Closing System

  • 8.1 Staked Needle System
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Luer Cone System
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Luer Lock Form System
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Diabetes
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Anaphylaxis
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Rheumatoid Arthritis
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Oncology
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 B. Braun Melsungen AG
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Baxter International Inc.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Bayer AG
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Becton Dickinson and Company
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Cardinal Health Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Catalent Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Fresenius SE & Co. KGaA
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Gerresheimer AG
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
    • 16.3.10 Nipro Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Schott AG
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 SWOT Analysis
    • 16.3.12 Terumo Corporation
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 West Pharmaceutical Services Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis